NASDAQFinancialsBanks - RegionalSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS at or above $0.2 in 2026 | A primary condition in Rhinebeck Bancorp, Inc.'s published investment case. The stated target is >=0.2 USD per share. | Intact | EPS falls below $0.2 in FY26 | Diluted EPS: $0.24 per share FY2026-Q2; GAAP. Published target: >=0.2 USD per share. Target period is not explicitly aligned with this observation. Source published Aug 13, 20260.24 USD/share · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b4412443-56b8-4a3c-a936-c5768e8c874b. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful execution of M&A agreements | A supporting condition in Rhinebeck Bancorp, Inc.'s published investment case. The stated target is Completion and integration of material agreements in 2026. | Improving | Failure to complete or integrate material M&A deals in 2026 | M&A activity confirmed (May 2026) May 2026 M&A activity event confirms entry into material definitive agreement for stock offering marketing. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Quarterly net income near $2.2M to $2.3M | It maintains consistent net income around $2.2M to $2.3M quarterly. | Intact | Net income falls below $2.2M in any quarter | Net income: $2.616M FY2026-Q2; GAAP. Published target: Net income >= $2.2M per quarter. Target period is not explicitly aligned with this observation. Source published Aug 13, 20262,616,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b4412443-56b8-4a3c-a936-c5768e8c874b. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Oct 27, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
RBKB is a regional banking business with a fragile earnings profile and elevated risk, rather than a clear durable compounder. Its long-term thesis is in a watch state: the recent signal improved mildly, but recent results remain weak relative to the industry cohort.
RBKB is valued at a discount to peers, while the expectations gap is negative, suggesting the market’s assumptions are cautious. The evidence labels this pricing justified and fragility low, so the discount does not by itself show that the business is undervalued.
Near term, earnings have improved modestly across the first two quarters of 2026, deposits grew, and management completed the conversion and capital raise as planned. Still, earnings quality is fragile and sector conditions are a headwind; a guidance cut or a shift toward rate cuts could add pressure. Management changes were reported as neutral, and detail on commercial banking expansion is limited.
The multi-year thesis depends on management delivering more consistent earnings and expanding deposits and commercial banking capabilities. Near-term risks include a guidance cut and rate cuts, while continued strong results and higher guidance from sector bellwethers could support sector momentum. Evidence on these scenarios remains limited.
Over the next 1 to 3 years, RBKB’s discounted valuation and execution progress are balanced by weak relative performance, fragile earnings quality, and elevated risk. The thesis remains watchful and depends on steadier operating results. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.